Tekla Life Sciences Stock Analysis
| HQL Stock | USD 16.81 0.23 1.35% |
Tekla Life Sciences is undervalued with Real Value of 19.15 and Hype Value of 16.73. The main objective of Tekla Life stock analysis is to determine its intrinsic value, which is an estimate of what Tekla Life Sciences is worth, separate from its market price. There are two main types of Tekla Life's stock analysis: fundamental analysis and technical analysis.
The Tekla Life stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. Tekla Stock Analysis Notes
About 30.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.98. Some equities with similar Price to Book (P/B) outperform the market in the long run. Tekla Life Sciences last dividend was issued on the 21st of November 2025. Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Tekla Life operates under Asset Management classification in the United States and is traded on New York Stock Exchange. To learn more about Tekla Life Sciences call the company at 215 405 5700 or check out https://www.teklacap.com/hql.html.Tekla Life Quarterly Total Revenue |
|
Tekla Life Sciences Investment Alerts
| Tekla Life Sciences has a strong financial position based on the latest SEC filings |
Tekla Market Capitalization
The company currently falls under 'Small-Cap' category with a total capitalization of 504.36 M.Tekla Profitablity
The company has Net Profit Margin of 44.16 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is very large. In the same way, it shows Net Operating Margin of (3.47) %, which entails that for every $100 of revenue, it lost $3.47.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.17 | 0.18 | |
| Return On Capital Employed | 0.17 | 0.18 | |
| Return On Assets | 0.17 | 0.18 | |
| Return On Equity | 0.17 | 0.18 |
Management Efficiency
Return On Tangible Assets is expected to rise to 0.18 this year. Return On Capital Employed is expected to rise to 0.18 this year. At this time, Tekla Life's Non Currrent Assets Other are quite stable compared to the past year. Return On Tangible Assets is expected to rise to 0.18 this year, although the value of Non Current Assets Total will most likely fall to about 337.8 M. Tekla Life's management efficiency ratios could be used to measure how well Tekla Life manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 14.74 | 14.29 | |
| Tangible Book Value Per Share | 14.74 | 14.29 | |
| Enterprise Value Over EBITDA | 4.37 | 3.14 | |
| Price Book Value Ratio | 0.83 | 0.70 | |
| Enterprise Value Multiple | 4.37 | 3.14 | |
| Price Fair Value | 0.83 | 0.70 | |
| Enterprise Value | 380.8 M | 268.5 M |
At Tekla Life Sciences, management's focus on innovation and efficiency has led to impressive financial results. We assess these factors to determine the stock's attractiveness to investors.
Technical Drivers
As of the 17th of December 2025, Tekla Life has the Semi Deviation of 1.25, coefficient of variation of 466.15, and Risk Adjusted Performance of 0.1547. Tekla Life technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Tekla Life Sciences downside deviation, jensen alpha, as well as the relationship between the Jensen Alpha and downside variance to decide if Tekla Life is priced more or less accurately, providing market reflects its prevalent price of 16.81 per share. Given that Tekla Life Sciences has jensen alpha of 0.2474, we advise you to double-check Tekla Life Sciences's current market performance to make sure the company can sustain itself at a future point.Tekla Life Sciences Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Mid-point Price over period is an average of Tekla Life Sciences highest and lowest prices attained during the given period.
Tekla Life Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tekla Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tekla Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tekla Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Tekla Life Outstanding Bonds
Tekla Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Tekla Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Tekla bonds can be classified according to their maturity, which is the date when Tekla Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Tekla Life Predictive Daily Indicators
Tekla Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Tekla Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 3278.78 | |||
| Daily Balance Of Power | (0.64) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 16.93 | |||
| Day Typical Price | 16.89 | |||
| Price Action Indicator | (0.24) | |||
| Period Momentum Indicator | (0.23) | |||
| Relative Strength Index | 55.42 |
Tekla Life Corporate Filings
| 8th of December 2025 Other Reports | ViewVerify | |
| 26th of November 2025 Other Reports | ViewVerify | |
F3 | 24th of November 2025 An amendment to the original Schedule 13D filing | ViewVerify |
F3 | 26th of September 2025 An amendment to the original Schedule 13D filing | ViewVerify |
F4 | 23rd of September 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 19th of September 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 17th of September 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 15th of September 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Tekla Life Forecast Models
Tekla Life's time-series forecasting models are one of many Tekla Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tekla Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Tekla Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Tekla Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tekla shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tekla Life. By using and applying Tekla Stock analysis, traders can create a robust methodology for identifying Tekla entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 1.13 | 1.07 | |
| Operating Profit Margin | 0.89 | 0.93 | |
| Net Profit Margin | 1.13 | 1.07 | |
| Gross Profit Margin | 0.42 | 0.44 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Tekla Life to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.594 | Dividend Share 1.82 | Earnings Share 2.79 | Revenue Per Share | Quarterly Revenue Growth (0.70) |
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.